←Back to Expert Scholars
Translational Medicine / 转化医学Immunotoxicology, IO Colitis
Yinghong Wang
MD, PhD
🏢MD Anderson Cancer Center🌐USA
Professor of Gastroenterology, Hepatology and Nutrition
48
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Yinghong Wang directs the MD Anderson immune checkpoint colitis program. Her work has established vedolizumab and fecal microbiota transplant as evidence-based treatments for refractory IO-induced colitis.
Share:
🧪Research Fields 研究领域
immune checkpoint colitis
vedolizumab irAE
infliximab IO
fecal microbiota transplant IO
IO GI toxicity guidelines
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Yinghong Wang 的研究动态
Follow Yinghong Wang's research updates
留下邮箱，当我们发布与 Yinghong Wang（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment